Existing literature in Lynch syndrome initially suggested the majority of patients carry MLH1 or MSH2 pathogenic variants, although analysis of multigene panel testing results suggest that the frequency is likely similar across the genes and analysis of international registries predicts that MSH6 and PMS2 pathogenic variants may be more common (2, 3). This evidence concerns the gene MLH1 and Lynch syndrome.